Patent directory · USPTO A61K / A61P
Patents matching “inhibitors”
2,466 pharma patents match "inhibitors" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 2,466 pharmaceutical patents matching "inhibitors" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 9243068
Combination of SEMA-4D inhibitors and immunomodulators to inhibit tumors and metastases
granted -
US 9242000
Micro-RNAs and micro-RNA inhibitors to modulate blood vessel growth, patterning, tumor growth and malignant disease and method for making and using them
granted -
US 9245290
Caspase inhibitors and uses thereof
granted -
US 9238676
Peptide and peptidomimetic inhibitors
granted -
US 9238653
Antimalarial agents that are inhibitors of dihydroorotate dehydrogenase
granted -
US 9233095
Small molecule RNase inhibitors and methods of use
granted -
US 9234000
Benzylamine derivatives as inhibitors of plasma kallikrein
granted -
AU 2014283378
2,3-dihydrobenzofuran-5-yl compounds as DYRK kinase inhibitors
granted -
US 9226921
Fused heterocyclic compounds as phosphodiesterases (PDES) inhibitors
granted -
US 9221838
Inhibitors of AKT activity
granted -
US 9221843
Heteroaryl inhibitors of PDE4
granted -
US 9221772
Synthesis of syrbactin proteasome inhibitors
granted -
US 9220748
Macrocyclic proline derived HCV serine protease inhibitors
granted -
US 9216983
Dihydroorotate dehydrogenase inhibitors with selective anti-malarial activity
granted -
US 9212149
Substituted 2-amidoquinazol-4-ones as matrix metalloproteinase-13 inhibitors
granted -
US 9212168
Hepatitis C virus inhibitors
granted -
US 9206183
Substituted pyrazolo[1,5-a]pyridines as JAK inhibitors
granted -
US 9206159
Piperazine-piperidine compounds as hepatitis C virus inhibitors
granted -
US 9206161
Bridged bicyclic heteroaryl substituted triazoles useful as Axl inhibitors
granted -
US 9207243
Use of GLUT4 inhibitors and DNA damaging agents for treating multiple myeloma
granted -
US 9198915
Methods involving aldose reductase inhibitors
granted -
US 9200025
Inhibitors of sodium glucose cotransporter 1
granted -
US 9193740
Bismacrocyclic compounds as hepatitis C virus inhibitors
granted -
US 9193722
Tri-cyclic pyrazolopyridine kinase inhibitors
granted